Axsome Therapeutics, Inc. (AXSM) stock
AXSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$134.00−1.95 (-1.43%)
Close on Nov 18, 2026Market cap $7.02BP/E –Yield –
Axsome Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Axsome Therapeutics's price to book ratio was 93.7× on Nov 11, 2026, against 103.4× a year earlier. Over the last 5 years it ranged from 10.4× to 230.6×, with a median of 68.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 93.7× | −30.9 |
| 2025 | Dec 31, 2025 | 124.6× | +80.5 |
| 2024 | Dec 31, 2024 | 44.1× | +30.1 |
| 2023 | Dec 29, 2023 | 14.0× | −7.3 |
| 2022 | Dec 30, 2022 | 21.3× | −12.0 |
| 2021 | Dec 31, 2021 | 33.3× | +10.8 |
| 2020 | Dec 31, 2020 | 22.5× | −176.6 |
| 2019 | Nov 29, 2019 | 199.1× | +98.6 |
| 2018 | Dec 31, 2018 | 100.5× | +92.6 |
| 2017 | Dec 29, 2017 | 7.9× | +3.3 |
| 2016 | Dec 30, 2016 | 4.6× | – |
See a number that looks wrong?